Last year, Delek delisted Gadot Biochemicals after an offer to purchase for NIS 8 million. The price reflected a 128% premium on Gadot Biochemicals' value at the time. However, Delek subsequently made a NIS 230 million write-off on Gadot Biochemicals in 2011.
FULL ARTICLE AT Globes Online